It is well known that the AIDS pandemic is a consequence of pandemic H
IV infection. However, Koch's postulates are not satisfied for two rea
sons: 1) AIDS cannot be experimentally produced in animals susceptible
to HIV infection and 2) some people have AIDS (idiopathic CD4(+) T ly
mphocytopenia) in the absence of HIV infection. It follows that there
is a human immunologic cofactor (HIC) that causes AIDS when certain ot
her conditions are satisfied, and the most common of these other condi
tions (but not the only one) is HIV infection. Results from microbiolo
gy make leukocyte adhesion molecules a good candidate for the HIC. We
have tested this hypothesis with a pilot study in which a small number
of patients with HIV disease were infused with a monoclonal mouse ant
ibody (MmAb) directed against an LFA-1 adhesion epitope, and then with
F(ab) and F(ab)(2)' fragments that bind to the same epitope but are n
onimmunogenic. Both agents reduced peripheral viral burden significant
ly but fragments were more effective in this respect than the MmAb due
to the mitogenic properties of the latter. For the same reason, only
the MmAb were highly effective in raising circulating levels of single
and double-marked CD4(+) T lymphocytes, with a correlated resolution
of cutaneous anergy.